Gene G. Olinger, Ph.D. - Publications

2001 Rush University, Chicago, IL, United States 
Microbiology Biology, Immunology

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, ... ... Olinger GG, et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Science Translational Medicine. 8: 326ra21. PMID 26888429 DOI: 10.1126/Scitranslmed.Aaf1061  0.4
2016 Johnson RF, Bagci U, Keith L, Tang X, Mollura DJ, Zeitlin L, Qin J, Huzella L, Bartos CJ, Bohorova N, Bohorov O, Goodman C, Kim DH, Paulty MH, Velasco J, ... ... Olinger GG, et al. 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology. 490: 49-58. PMID 26828465 DOI: 10.1016/J.Virol.2016.01.004  0.4
2016 Zeitlin L, Whaley KJ, Olinger GG, Jacobs M, Gopal R, Qiu X, Kobinger GP. Antibody therapeutics for Ebola virus disease. Current Opinion in Virology. 17: 45-49. PMID 26826442 DOI: 10.1016/j.coviro.2016.01.006  0.4
2015 McMullan LK, Flint M, Dyall J, Albariño C, Olinger G, Foster S, Sethna P, Hensley LE, Nichol ST, Lanier ER, Spiropoulou CF. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. Antiviral Research. PMID 26526586 DOI: 10.1016/j.antiviral.2015.10.010  0.4
2015 Fusco ML, Hashiguchi T, Cassan R, Biggins JE, Murin CD, Warfield KL, Li S, Holtsberg FW, Shulenin S, Vu H, Olinger GG, Kim DH, Whaley KJ, Zeitlin L, Ward AB, et al. Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs. Plos Pathogens. 11: e1005212. PMID 26452225 DOI: 10.1371/Journal.Ppat.1005212  0.4
2015 Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. Journal of Virology. 89: 9932-8. PMID 26202243 DOI: 10.1128/Jvi.01337-15  0.4
2015 Meyer M, Garron T, Lubaki NM, Mire CE, Fenton KA, Klages C, Olinger GG, Geisbert TW, Collins PL, Bukreyev A. Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. The Journal of Clinical Investigation. 125: 3241-55. PMID 26168222 DOI: 10.1172/Jci81532  0.4
2015 Fusco ML, Hashiguchi T, Cassan R, Biggins JE, Murin CD, Warfield KL, Li S, Holtsberg FW, Shulenin S, Vu H, Olinger GG, Kim DH, Whaley KJ, Zeitlin L, Ward AB, et al. Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs. Plos Pathogens. 11: e1005016. PMID 26115029 DOI: 10.1371/Journal.Ppat.1005016  0.4
2015 Johansen LM, DeWald LE, Shoemaker CJ, Hoffstrom BG, Lear-Rooney CM, Stossel A, Nelson E, Delos SE, Simmons JA, Grenier JM, Pierce LT, Pajouhesh H, Lehár J, Hensley LE, Glass PJ, ... ... Olinger GG, et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Science Translational Medicine. 7: 290ra89. PMID 26041706 DOI: 10.1126/Scitranslmed.Aaa5597  0.4
2015 Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, Eller MA, Eller LA, Michael NL, Honko AN, Olinger GG, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. The Lancet. Infectious Diseases. PMID 25910637 DOI: 10.1016/S1473-3099(15)70152-0  0.4
2015 O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. Journal of Virology. 89: 5441-9. PMID 25741008 DOI: 10.1128/Jvi.03689-14  0.4
2015 Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, Olinger GG, Hensley LE, Jahrling PB. Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrobial Agents and Chemotherapy. 59: 1088-99. PMID 25487801 DOI: 10.1128/Aac.03659-14  0.4
2014 Murin CD, Fusco ML, Bornholdt ZA, Qiu X, Olinger GG, Zeitlin L, Kobinger GP, Ward AB, Saphire EO. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proceedings of the National Academy of Sciences of the United States of America. 111: 17182-7. PMID 25404321 DOI: 10.1073/Pnas.1414164111  0.4
2014 Garrison AR, Giomarelli BG, Lear-Rooney CM, Saucedo CJ, Yellayi S, Krumpe LR, Rose M, Paragas J, Bray M, Olinger GG, McMahon JB, Huggins J, O'Keefe BR. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research. 112: 1-7. PMID 25265598 DOI: 10.1016/J.Antiviral.2014.09.012  0.4
2014 Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, ... ... Olinger GG, et al. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses. 6: 3663-82. PMID 25256396 DOI: 10.3390/V6093663  0.4
2014 Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, ... ... Olinger GG, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 514: 47-53. PMID 25171469 DOI: 10.1038/nature13777  0.4
2014 Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy. 58: 4885-93. PMID 24841273 DOI: 10.1128/Aac.03036-14  0.4
2014 Johnson JC, Martinez O, Honko AN, Hensley LE, Olinger GG, Basler CF. Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Research. 107: 102-9. PMID 24815087 DOI: 10.1016/J.Antiviral.2014.04.014  0.4
2014 Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. The Journal of General Virology. 95: 571-7. PMID 24323636 DOI: 10.1099/Vir.0.061911-0  0.4
2014 Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2  0.4
2013 Pettitt J, Zeitlin L, Kim do H, Working C, Johnson JC, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly MH, Whaley KJ, Ingram MF, Zovanyi A, ... ... Olinger GG, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Science Translational Medicine. 5: 199ra113. PMID 23966302 DOI: 10.1126/scitranslmed.3006608  0.4
2013 Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, Lehár J, Hensley LE, White JM, Olinger GG. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Science Translational Medicine. 5: 190ra79. PMID 23785035 DOI: 10.1126/Scitranslmed.3005471  0.4
2013 Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. Journal of Virological Methods. 193: 565-71. PMID 23748121 DOI: 10.1016/j.jviromet.2013.05.015  0.4
2013 Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, Sarraju A, Sokolovska A, Zariffard MR, Eisen DP, Mungall BA, Kotton DN, Omari A, Huang IC, Farzan M, ... ... Olinger GG, et al. Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. Plos One. 8: e60838. PMID 23573288 DOI: 10.1371/Journal.Pone.0060838  0.44
2013 Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. Plos One. 8: e56265. PMID 23441171 DOI: 10.1371/Journal.Pone.0056265  0.4
2013 Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE, Stonier SW, Muhammad MA, Bakken RR, Prugar LI, Olinger GG, Groebner JL, Lee JS, Pratt WD, Custer M, et al. Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. Journal of Virology. 87: 4952-64. PMID 23408633 DOI: 10.1128/JVI.03361-12  0.4
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 1425-32. PMID 23358612 DOI: 10.1007/S00705-012-1594-2  0.4
2013 Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, Olinger GG, Basler CF. Ebola virus exploits a monocyte differentiation program to promote its entry. Journal of Virology. 87: 3801-14. PMID 23345511 DOI: 10.1128/Jvi.02695-12  0.4
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, ... ... Olinger GG, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 301-11. PMID 23001720 DOI: 10.1007/S00705-012-1454-0  0.4
2012 Shurtleff AC, Biggins JE, Keeney AE, Zumbrun EE, Bloomfield HA, Kuehne A, Audet JL, Alfson KJ, Griffiths A, Olinger GG, Bavari S. Standardization of the filovirus plaque assay for use in preclinical studies. Viruses. 4: 3511-30. PMID 23223188 DOI: 10.3390/v4123511  0.4
2011 Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, Pauly M, Hiatt A, Ngo L, Steinkellner H, Whaley KJ, Olinger GG. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant Proceedings of the National Academy of Sciences of the United States of America. 108: 20690-20694. PMID 22143789 DOI: 10.1073/Pnas.1108360108  0.4
2011 Kortepeter MG, Lawler JV, Honko A, Bray M, Johnson JC, Purcell BK, Olinger GG, Rivard R, Hepburn MJ, Hensley LE. Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus. The Journal of Infectious Diseases. 204: S1000-10. PMID 21987736 DOI: 10.1093/infdis/jir337  0.4
2011 Michelow IC, Lear C, Scully C, Prugar LI, Longley CB, Yantosca LM, Ji X, Karpel M, Brudner M, Takahashi K, Spear GT, Ezekowitz RA, Schmidt EV, Olinger GG. High-dose mannose-binding lectin therapy for Ebola virus infection. The Journal of Infectious Diseases. 203: 175-9. PMID 21288816 DOI: 10.1093/Infdis/Jiq025  0.44
2010 Michelow IC, Dong M, Mungall BA, Yantosca LM, Lear C, Ji X, Karpel M, Rootes CL, Brudner M, Houen G, Eisen DP, Kinane TB, Takahashi K, Stahl GL, Olinger GG, et al. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. The Journal of Biological Chemistry. 285: 24729-39. PMID 20516066 DOI: 10.1074/Jbc.M110.106260  0.4
2010 Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology. 12: 148-57. PMID 19775255 DOI: 10.1111/J.1462-5822.2009.01385.X  0.4
2009 Kalina WV, Warfield KL, Olinger GG, Bavari S. Discovery of common marburgvirus protective epitopes in a BALB/c mouse model. Virology Journal. 6: 132. PMID 19712478 DOI: 10.1186/1743-422X-6-132  0.4
2008 Anzinger JJ, Olinger GG, Spear GT. Donor variability in HIV binding to peripheral blood mononuclear cells. Virology Journal. 5: 95. PMID 18706090 DOI: 10.1186/1743-422X-5-95  0.44
2007 Warfield KL, Alves DA, Bradfute SB, Reed DK, VanTongeren S, Kalina WV, Olinger GG, Bavari S. Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virology Journal. 4: 108. PMID 17961252 DOI: 10.1186/1743-422X-4-108  0.4
2007 Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. The Journal of Infectious Diseases. 196: S430-7. PMID 17940980 DOI: 10.1086/520583  0.4
2007 Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D, Gillette WK, Hopkins RF, Costantino J, Panchal RG, Hartley JL, Aman MJ, Bavari S. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. The Journal of Infectious Diseases. 196: S421-9. PMID 17940979 DOI: 10.1086/520612  0.4
2007 Warfield KL, Swenson DL, Olinger GG, Kalina WV, Viard M, Aitichou M, Chi X, Ibrahim S, Blumenthal R, Raviv Y, Bavari S, Aman MJ. Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. The Journal of Infectious Diseases. 196: S276-83. PMID 17940961 DOI: 10.1086/520605  0.4
2006 Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, Fuller CL, Swenson DL, Pratt WD, Kuhns DB, Schmaljohn AL. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. Journal of Virology. 80: 7235-44. PMID 16809329 DOI: 10.1128/Jvi.00543-06  0.4
2006 Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. Plos Pathogens. 2: e1. PMID 16415982 DOI: 10.1371/journal.ppat.0020001  0.4
2005 Olinger GG, Bailey MA, Dye JM, Bakken R, Kuehne A, Kondig J, Wilson J, Hogan RJ, Hart MK. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. Journal of Virology. 79: 14189-96. PMID 16254354 DOI: 10.1128/Jvi.79.22.14189-14196.2005  0.4
2005 Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. The Journal of General Virology. 86: 2535-42. PMID 16099912 DOI: 10.1099/Vir.0.81199-0  0.44
2002 Olinger GG, Saifuddin M, Hart ML, Spear GT. Cellular factors influence the binding of HIV type 1 to cells. Aids Research and Human Retroviruses. 18: 259-67. PMID 11860673 DOI: 10.1089/088922202753472838  0.4
2001 Spear GT, Hart M, Olinger GG, Hashemi FB, Saifuddin M. The role of the complement system in virus infections. Current Topics in Microbiology and Immunology. 260: 229-45. PMID 11443876  0.44
2001 Spear GT, Olinger GG, Saifuddin M, Gebel HM. Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement. Journal of Acquired Immune Deficiency Syndromes (1999). 26: 103-10. PMID 11242176 DOI: 10.1097/00042560-200102010-00001  0.44
2000 Olinger GG, Saifuddin M, Spear GT. CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. Journal of Virology. 74: 8550-7. PMID 10954556 DOI: 10.1128/Jvi.74.18.8550-8557.2000  0.44
1999 Olinger GG, Hashemi FB, Sha BE, Spear GT. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. Aids (London, England). 13: 1905-12. PMID 10513649 DOI: 10.1097/00002030-199910010-00013  0.4
1999 Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, Spear GT. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. Journal of Acquired Immune Deficiency Syndromes (1999). 21: 194-202. PMID 10421242 DOI: 10.1097/00126334-199907010-00003  0.4
Show low-probability matches.